Trial Profile
Effect of Injection Site on the Relative and Absolute Bioavailability of Single Dose of LY900014 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 May 2022
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary) ; Insulin lispro
- Indications Diabetes mellitus; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 13 May 2022 Results comparing the pharmacokinetic profile and glucodynamic response of URLi when administered subcutaneously into the abdomen, upper arm, or thigh, published in the Clinical Therapeutics
- 04 Dec 2017 Status changed from active, no longer recruiting to completed.
- 20 Oct 2017 Status changed from recruiting to active, no longer recruiting.